| Catalog No. | HB132016 |
| Brand | abinScience |
| Host species | Mouse |
| Species reactivity | Human |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Purity | >95% purity as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG2a, kappa |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target | Alpha-(1, 3)-fucosyltransferase 4, ELAM-1 ligand fucosyltransferase, Fucosyltransferase 4, Fucosyltransferase IV, Galactoside 3-L-fucosyltransferase, Fuc-TIV, FCT3A, FUT4, ELFT, FucT-IV |
| References | 1. Klingensmith WC 3rd, et al. Intrapatient comparison of 2-deoxy-2-[F-18]fluoro-D-glucose with positron emissiontomography/computed tomography to Tc-99m fanolesomab (NeutroSpec) for localization of infection. Mol Imaging Biol. 2007;9(5):295-299. [HB132016] |
| Purification | Protein A/G purified from cell culture supernatant. |
| Biological activity | Fanolesomab uses a technetium-99m label, enables white blood cell labeling, eliminates need for handling blood products, and is readily available. Fanolesomab exhibits 100% specificity in infection imaging [1]. |
| Endotoxin level | < 10 EU/mg |
| Expression system | Mammalian cells |
| Accession | P22083 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | Fanolesomab |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Anti-Human CD15/Lewis X Reference Antibody (Fanolesomab, RUO)
Overview
Images
 Bioactivity |
SEC-HPLC detection for Research Grade Fanolesomab. |
 SDS-PAGE |
SDS-PAGE for Research Grade Fanolesomab. |